A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)

We examined the dosing regimens, compliance, and outcomes of premature infants who received palivizumab within the Canadian Registry of Palivizumab (CARESS). Infants receiving ≥1 dose of palivizumab during the 2006–2011 respiratory syncytial virus (RSV) seasons were recruited across 30 sites. Respir...

Descripción completa

Detalles Bibliográficos
Autores principales: Paes, B., Mitchell, I., Li, A., Lanctôt, K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456915/
https://www.ncbi.nlm.nih.gov/pubmed/22546928
http://dx.doi.org/10.1007/s10096-012-1617-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456915/
https://www.ncbi.nlm.nih.gov/pubmed/22546928
http://dx.doi.org/10.1007/s10096-012-1617-7

Ejemplares similares